Cetuximab-Induced Aseptic Meningitis in a Patient with Colorectal Cancer: A Case Report and Review of Literature

Jakob Jäger(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bastian Volbers(Friedrich-Alexander-Universität Erlangen-Nürnberg), Francesco Vitali(Friedrich-Alexander-Universität Erlangen-Nürnberg), Tamara Brunner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Axel Wein(Friedrich-Alexander-Universität Erlangen-Nürnberg), Maximilian I. Sprügel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Martin Uhl(Friedrich-Alexander-Universität Erlangen-Nürnberg), Stefan Schwab(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Case Reports in Neurology
November 28, 2022
10.1159/000527075
Cited by 5

Related Papers

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
|The Lancet|2019|524
SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells<b><i>In vitro</i></b>and<b><i>In vivo</i></b>
|Cancer Research|2004|411
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
|Journal of Clinical Oncology|2016|197
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
|The Lancet|2020|190